Merck’s Winrevair Approved For PAH In Europe As Initial US Launch Progresses

Q1 Revenue Totaled $70m, 60% From Stocking

 
• By Mandy Jackson
  
PULMONARY HYPERTENSION Top view, Doctor writing medical records on a clipboard, medical equipment
Winrevair was approved in Europe for use on top of other PAH medicines • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from New Products

More from Scrip